Stock Research for UTHR


Featured Broker: Ally Invest

Get the due diligence for another stock.


UTHR Stock Chart & Research Data

The UTHR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the UTHR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


UTHR Due diligence Resources & Stock Charts

The UTHR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View UTHR Detailed Price Forecast - CNN Money CNN View UTHR Detailed Summary - Google Finance
Yahoo View UTHR Detailed Summary - Yahoo! Finance Zacks View UTHR Stock Research & Analysis -

Stock Analysis

TradeIdeas View UTHR Trends & Analysis - Trade-Ideas Barrons View UTHR Major Holders - Barrons
NASDAQ View UTHR Call Transcripts - NASDAQ Seeking View UTHR Breaking News & Analysis - Seeking Alpha
Spotlight View UTHR Annual Report - OTC Report View UTHR OTC Short Report -
TradeKing View UTHR Fundamentals - TradeKing Charts View UTHR SEC Filings - Bar Chart
WSJ View Historical Prices for UTHR - The WSJ Morningstar View Performance/Total Return for UTHR - Morningstar
MarketWatch View the Analyst Estimates for UTHR - MarketWatch CNBC View the Earnings History for UTHR - CNBC
StockMarketWatch View the UTHR Earnings - StockMarketWatch MacroAxis View UTHR Buy or Sell Recommendations - MacroAxis
Bullish View the UTHR Bullish Patterns - American Bulls Short Pains View UTHR Short Pain Metrics -

Social Media Mentions

StockTwits View UTHR Stock Mentions - StockTwits PennyStocks View UTHR Stock Mentions - PennyStockTweets
Twitter View UTHR Stock Mentions - Twitter Invest Hub View UTHR Investment Forum News - Investor Hub
Yahoo View UTHR Stock Mentions - Yahoo! Message Board Seeking Alpha View UTHR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for UTHR - Insider Cow View Insider Transactions for UTHR - Insider Cow
CNBC View UTHR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for UTHR - OTC Markets
Yahoo View Insider Transactions for UTHR - Yahoo! Finance NASDAQ View Institutional Holdings for UTHR - NASDAQ

Stock Charts

FinViz View UTHR Stock Insight & Charts - StockCharts View UTHR Investment Charts -
BarChart View UTHR Stock Overview & Charts - BarChart Trading View View UTHR User Generated Charts - Trading View

Latest Financial News for UTHR

SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results
Posted on Tuesday May 15, 2018

SAN RAMON, Calif., May 15, 2018-- SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral ...

See what the IHS Markit Score report has to say about United Therapeutics Corp.
Posted on Wednesday May 09, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

Analysts: Generic drugs won’t affect United Therapeutics ‘that much’
Posted on Tuesday May 08, 2018

The Silver Spring biotech is seeing patents expire on some of its key drugs, a longstanding problem. But two analysts say it may not be as bad as it appears.

Jazz Pharmaceuticals to settle U.S. probe for $57 million
Posted on Tuesday May 08, 2018

Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance to Medicare patients seeking help to cover out-of-pocket drug costs. The drugmaker said in a filing with the U.S. Securities and Exchange Commission that it reached an agreement in principle with the U.S. Justice Department to pay the sum as part of a civil settlement. Jazz, which produces the expensive narcolepsy drug Xyrem, said in the filing it could not guarantee its efforts to reach a final settlement would be successful.

Enter a stock symbol to view the stock details.